Last reviewed · How we verify
Clareon PanOptix PRO — Competitive Intelligence Brief
marketed
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
Clareon PanOptix PRO (Clareon PanOptix PRO) — Berkeley Eye Center. Clareon PanOptix PRO is a trifocal intraocular lens that provides simultaneous vision at multiple focal distances through diffractive optics.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Clareon PanOptix PRO TARGET | Clareon PanOptix PRO | Berkeley Eye Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Clareon PanOptix PRO CI watch — RSS
- Clareon PanOptix PRO CI watch — Atom
- Clareon PanOptix PRO CI watch — JSON
- Clareon PanOptix PRO alone — RSS
Cite this brief
Drug Landscape (2026). Clareon PanOptix PRO — Competitive Intelligence Brief. https://druglandscape.com/ci/clareon-panoptix-pro. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing